Identification of Novel Gene Signature Associated with Cell Glycolysis to Predict Survival in Hepatocellular Carcinoma Patients

Figure 8

Kaplan–Meier curves for the prognostic value of risk parameter signature for the patients divided by each clinical feature. (a) Age, (b) gender, (c) grade, (d) stage I-II, (e) T1-2, (f) M0, and (g) N0.

(a)

(b)

(c)

(d)

(e)

(f)

(g)